GPT and metabolic dysfunction-associated steatotic liver disease: Even though most residents accurately recognized the risk of NAFLD despite normal ALT levels (93.5%, Table 2), it was infrequently discussed, while significantly more likely discussed with patients with elevated ALT (see Supplemental Digital Content Figure 1, http://links.lww.com/PG9/A88).